𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib

✍ Scribed by Trevor McKibbin; Wei Zhao; Michael Tagen; Najat C. Daw; Wayne L. Furman; Lisa M. McGregor; J. Russell Geyer; Jeffrey W. Allen; Clinton F. Stewart


Book ID
116430422
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
155 KB
Volume
46
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The impact of epidermal growth factor re
✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 403 KB πŸ‘ 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor